StonvexLoading…
StonvexStonvexStonvexCore line items from MRAM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $55.20M | $50.40M | $63.77M | $59.98M |
Operating Income | $-6.51M | $-7.09M | $5.88M | $6.23M |
Net Income | $-586.00K | $781.00K | $9.05M | $6.13M |
EPS (Diluted) | $-0.03 | $0.04 | $0.42 | $0.29 |
Total Assets | $84.61M | $77.79M | $67.30M | $55.33M |
Total Liabilities | $15.69M | $15.20M | $13.38M | $16.67M |
Cash & Equivalents | $44.45M | $42.10M | $36.95M | $26.80M |
Free Cash Flow OCF − CapEx | $3.12M | $4.05M | $11.72M | $6.71M |
Shares Outstanding | 22.98M | 22.06M | 21.08M | 20.37M |